e-Health and Co-production: Critical Drivers for Chronic Diseases Management

A progressively ageing population makes the healthcare management of chronic diseases (e.g. heart failure (HF), diabetes, geriatric psychosis) an extremely relevant matter for worldwide national health systems, as chronicity persists for a long time and generally cannot be permanently cured. In order to ensure the economic and social sustainability of treating such diseases, new healthcare business models, based on innovative tools and patients’ participation, should be considered. The adoption of new technologies and the active involvement of patients in the therapeutic pathway might represent fundamental drivers in healthcare delivery innovation. Accordingly, empirical evidence about Chronic Diseases Management, based on new technologies, such as remote monitoring (RM) systems, shows how patients are enabled to actively take part in the follow-up process. This “co-production” approach to the service has shown a reduction in health organizations’ workload for the same level of outcome (e.g. hospitalization rate reduction), suggesting new opportunities in the design of healthcare delivery systems. Moreover, within this evidence, end-users’ (patients and their caregivers) collaboration, i.e. more skilled and ICT-adoption oriented, represents strong support to the medical profession, as well as to patients’ satisfaction and loyalty. Drawing from these premises, this work aims at summarizing Italian empirical evidence highlighted through the case study method) of co-production and telemedicine joint implementation. Specifically, through such evidence, we aim to describe how e-Health and co-production could prove to be crucial organizational drivers in Chronic Diseases Management, both in cost reduction and in service (outcome) innovation.

[1]  F. Rengo,et al.  Epidemiologia clinica e fattori di rischio per scompenso cardiaco nell'anziano , 2004 .

[2]  W. Rand,et al.  Randomized, Controlled Evaluation of Short- and Long-Term Benefits of Heart Failure Disease Management Within a Diverse Provider Network: The SPAN-CHF Trial , 2004, Circulation.

[3]  G. Sinagra,et al.  La prevenzione dello scompenso cardiaco , 2010 .

[4]  G. Wells,et al.  Comparative Effectiveness of Different Forms of Telemedicine for Individuals with Heart Failure (HF): A Systematic Review and Network Meta-Analysis , 2015, PloS one.

[5]  Michel Chauvin,et al.  Potential Cost Savings by Telemedicine‐Assisted Long‐Term Care of Implantable Cardioverter Defibrillator Recipients , 2005, Pacing and clinical electrophysiology : PACE.

[6]  N Freemantle,et al.  The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. , 2003, European heart journal.

[7]  Tim Baker,et al.  Economic burden of heart failure: a summary of recent literature. , 2004, Heart & lung : the journal of critical care.

[8]  P. Thokala,et al.  Telemonitoring after discharge from hospital with heart failure: cost-effectiveness modelling of alternative service designs , 2013, BMJ Open.

[9]  Dominique Lacroix,et al.  A randomized study of remote follow-up of implantable cardioverter defibrillators: safety and efficacy report of the ECOST trial , 2012, European heart journal.

[10]  Antonio Chirico,et al.  Cost accounting del follow-up annuo per il controllo remoto dei defibrillatori impiantabili , 2014 .

[11]  Kathryn H. Dansky,et al.  Impact of Telehealth on Clinical Outcomes in Patients With Heart Failure , 2008, Clinical nursing research.

[12]  P. Brugada,et al.  Remote monitoring: a cost or an investment? , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[13]  C. Sousa,et al.  Telemonitoring in heart failure: a state-of-the-art review. , 2014, Revista Portuguesa de Cardiologia.

[14]  M. Cowie,et al.  Telemonitoring in heart failure , 2009, Heart.

[15]  J. Yang Of markets and rights: Discourse in the 2008 and 2013 Global Action Plan for the Prevention and Control of Noncommunicable Diseases , 2016 .

[16]  M. Patton,et al.  Qualitative evaluation and research methods , 1992 .

[17]  B. Avitall,et al.  Outcomes of chronic heart failure. , 2003, Archives of internal medicine.

[18]  J. Concato,et al.  Patterns of Weight Change Preceding Hospitalization for Heart Failure , 2007, Circulation.

[19]  L. Tavazzi,et al.  Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial. , 2011, European heart journal.

[20]  Ayesha Hasan,et al.  Telemonitoring in chronic heart failure. , 2011, European heart journal.

[21]  Giovanni Pulignano,et al.  Two-year outcome of a prospective, controlled study of a disease management programme for elderly patients with heart failure , 2007, Journal of cardiovascular medicine.

[22]  Henry Chesbrough,et al.  Open Innovation: The New Imperative for Creating and Profiting from Technology , 2003 .

[23]  M. Linnaluoto,et al.  Remote monitoring of implantable cardioverter defibrillator patients: a safe, time-saving, and cost-effective means for follow-up , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[24]  J. McMurray,et al.  Clinical epidemiology of heart failure: public and private health burden. , 1998, European heart journal.

[25]  J. West,et al.  Managing Distributed Innovation: Strategic Utilization of Open and User Innovation , 2012 .

[26]  Edgar S. Cahn,et al.  No More Throw-Away People: The Co-Production Imperative , 2004 .

[27]  P. Hebert,et al.  Cost-Effectiveness of Nurse-Led Disease Management for Heart Failure in an Ethnically Diverse Urban Community , 2008, Annals of Internal Medicine.

[28]  Leora I. Horwitz,et al.  Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia. , 2013, JAMA.

[29]  Maurizio Marzegalli,et al.  Remote Monitoring Reduces Healthcare Use and Improves Quality of Care in Heart Failure Patients With Implantable Defibrillators: The Evolution of Management Strategies of Heart Failure Patients With Implantable Defibrillators (EVOLVO) Study , 2012, Circulation.

[30]  N. Freemantle,et al.  The EuroHeart Failure Survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment , 2003 .

[31]  Randall S. Brown,et al.  Impacts of a Disease Management Program for Dually Eligible Beneficiaries , 2008, Health care financing review.

[32]  Banafsheh Sadeghi,et al.  A remote monitoring and telephone nurse coaching intervention to reduce readmissions among patients with heart failure: study protocol for the Better Effectiveness After Transition - Heart Failure (BEAT-HF) randomized controlled trial , 2014, Trials.

[33]  Mark A Hlatky,et al.  2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. , 2013, Circulation.

[34]  Renato Pietro Ricci,et al.  HRS Expert Consensus Statement on remote interrogation and monitoring for cardiovascular implantable electronic devices. , 2015, Heart rhythm.

[35]  R. Yin Case Study Research: Design and Methods , 1984 .

[36]  D. Cepiku,et al.  Co-Production in Developing Countries: Insights from the community health workers experience , 2014 .

[37]  J. Cleland,et al.  Should we screen for asymptomatic left ventricular dysfunction to prevent heart failure? , 1998, European heart journal.

[38]  F. Forastiere,et al.  Prevalence of preclinical and clinical heart failure in the elderly. A population‐based study in Central Italy , 2012, European journal of heart failure.

[39]  G. Hindricks,et al.  Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial , 2014, The Lancet.

[40]  P. Ponikowski,et al.  EURObservational Research Programme: The Heart Failure Pilot Survey (ESC‐HF Pilot) , 2010, European journal of heart failure.

[41]  A. Rigby,et al.  Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death: the Trans-European Network-Home-Care Management System (TEN-HMS) study. , 2005, Journal of the American College of Cardiology.

[42]  S. Osborne,et al.  Co-Production and the Co-Creation of Value in Public Services: A suitable case for treatment? , 2016 .

[43]  A. Capucci,et al.  A New Electrocardiographic Marker of Sudden Death in Brugada Syndrome: The S-Wave in Lead I. , 2016, Journal of the American College of Cardiology.

[44]  R. Spitzer,et al.  The PHQ-9 , 2001, Journal of General Internal Medicine.

[45]  Guy Paré,et al.  Effects of Home Telemonitoring Interventions on Patients With Chronic Heart Failure: An Overview of Systematic Reviews , 2015, Journal of medical Internet research.

[46]  A. Chirico,et al.  Economic impact of remote monitoring on ordinary follow-up of implantable cardioverter defibrillators as compared with conventional in-hospital visits. A single-center prospective and randomized study , 2013, Journal of Interventional Cardiac Electrophysiology.